Print version

pdf Click to download

Search Pub Med

Back
026P Queen Elizabeth II Conference Centre London
BPS Winter Meeting 2012

 

 

The Binding of Calcitonin to its Receptor; Studies by Mutagenesis and Molecular Modelling

J Barwell1, J Gingell2, DR Poyner1, DL Hay2. 1School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK, 2School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1142, New Zealand

 

The calcitonin (CT) receptor (CTR) is an example of a family B G protein-coupled receptor (GPCR). It is not known how CT binds to its receptor. Here, site-directed mutagenesis and molecular modelling have been used to identify likely receptor-ligand contacts.

Mutagenesis of the human CTR(a), transient transfection into Cos 7 cells, challenge with human CT and measurement of cAMP were as described previously (1). Data were fitted with Graphpad Prism 5 using a logistic equation with fixed Hill slope to obtain pEC50 values. To model the CTR extracellular domain (ECD) (the expected major domain involved in binding), the crystal structure of the CTR-like receptor ECD (PDB 3N7S) was used (2). An homology model was made using Modeller 9v8, (3). Human CT (PDB 2JXZ) was docked using ClusPro 2.0 (4).

The mutagenesis data (Table 1) indicated that residues clustered on the presumed helix 1, loops 2 and 4 and the C-terminus of CTR all influenced binding of CT. These residues define a similar binding pocket to that observed for the binding of certain other family B GPCR ligands to their receptors (5).

Table 1 Effects of mutants on the pEC50 of human CT to stimulate cAMP production

Mutant pEC50 WT pEC50 mutant Interaction with residue in CTR
M48A 9.25 ± 0.16 8.78 ± 0.18* Packs against F16
Q52A 9.48 ± 0.21 9.35 ± 0.23
Y53A 9.53 ± 0.51 9.43 ± 0.13
Y56A 10.1 ± 0.19 10.1 ± 0.26
W79A 9.33 ± 0.22 8.08 ± 0.13* Packs against F16, H17 and H20
F99A 9.51 ± 0.24 8.64 ± 0.15* Packs against L12 and F16
D101A 9.70 ± 0.15 8.71 ± 0.09* Hydrogen bond with T13
F102A 9.50 ± 0.17 7.37 ± 0.17* Packs against H17
W128A 10.4 ± 0.1 7.97 ± 0.08* Packs against H20
Y131A 9.35 ± 0.24 8.52 ± 0.15* Packs against W79 of CTR

Values are means ± sems of 3-5 determinations. *, P<0.05, Student’s t-test.

Molecular modelling suggests that the residues identified in the mutagenesis form hydrophobic or hydrogen bonds with amino acids along bound CT. This provides a plausible model for the docking of human CT.

 

References

1. Bailey, R. J., Walker, C. S., Ferner, A. H., Loomes, K. M., Prijic, G., Halim, A., Whiting, L., Phillips, A. R., and Hay, D. L. (2012) Br J Pharmacol 166, 151-167

2. ter Haar, E., Koth, C. M., Abdul-Manan, N., Swenson, L., Coll, J. T., Lippke, J. A., Lepre, C. A., Garcia-Guzman, M., and Moore, J. M. (2010) Structure 18, 1083-1093

3. Barwell, J., Miller, P. S., Donnelly, D., and Poyner, D. R. (2010) Peptides 31, 170-176

4. Kozakov, D., Hall, D. R., Beglov, D., Brenke, R., Comeau, S. R., Shen, Y., Li, K., Zheng, J., Vakili, P., Paschalidis, I., and Vajda, S. (2010) Proteins 78, 3124-3130

5. Runge, S., Thogersen, H., Madsen, K., Lau, J., and Rudolph, R. (2008) J Biol Chem 283, 11340-11347